Arteris (AIP) is drawing fresh attention as investors focus on its role supplying network on chip technology that supports increasingly complex AI oriented semiconductors and advanced architectures used in data centers and automotive systems.

At a share price of $41.56, Arteris has seen strong momentum, with a 90 day share price return of 160.40% and a one year total shareholder return of about 7x, even after a 1 day pullback of 4.74%.

If Arteris has you rethinking where AI infrastructure fits in your portfolio, this is a good moment to scan for other potential beneficiaries using our 48 AI infrastructure stocks

With Arteris stock up sharply over the past year, yet still trading below the average analyst price target, the key question is whether investors are underestimating its role in AI chips or already pricing in years of future growth.

Most Popular Narrative: 103% Overvalued

With Arteris stock at $41.56 versus a narrative fair value of $20.50, the current price sits well above the consensus modelling of its future fundamentals.

The ongoing industry transition to chiplet-based and heterogeneous integration architectures is expanding Arteris' addressable market, with chiplet-related design starts expected to rise from 5% to 30% in coming years; this structural trend supports both higher sales volume and increased average selling prices, benefiting future top-line revenue. Arteris' launch of innovative products such as FlexGen and Magillem Packaging, which have been recognized with industry awards and integrated into leading chipmaker portfolios, raises the technological moat, improving competitive positioning and enabling potential margin expansion through pricing power.

Want to see how this chiplet and AI demand story translates into long term revenue, margins, and a very rich future earnings multiple? The key narrative ties fast top line expansion, a swing in profitability, and a premium valuation that leans heavily on what Arteris might earn several years from now.

Result: Fair Value of $20.50 (OVERVALUED)

However, the Arteris narrative still hinges on a few pressure points, including reliance on large customers and ongoing losses that could weigh on sentiment if the company’s growth slows.

Next Steps

With enthusiasm around Arteris running high but clear questions on risk still in play, it makes sense to move quickly and stress test the story against the numbers and assumptions that matter most. To weigh those bright spots against the potential weak links, start by reviewing the 1 key reward and 2 important warning signs

Looking for more investment ideas beyond Arteris stock?

If Arteris has sharpened your interest in AI and high growth themes, do not stop here. Broaden your watchlist with a few focused stock idea lists.

• Target potential value opportunities by checking companies that screen as quality and priced below their estimated worth through the 44 high quality undervalued stocks.
• Strengthen your income stream by reviewing companies with higher yields and resilient payouts using the 9 dividend fortresses.
• Prioritise resilience by scanning companies that rank well for financial robustness with the 67 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.